Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Trin Therapeutics GmbH.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
University Hospital, Essen
Central European Society for Anticancer Drug Research
Assign Data Management and Biostatistics GmbH
Information provided by:
Trin Therapeutics GmbH
ClinicalTrials.gov Identifier:
NCT01259518
First received: November 24, 2010
Last updated: June 6, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2012
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)